Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies.
Maillart E, Durand-Dubief F, Louapre C, Audoin B, Bourre B, Derache N, Ciron J, Collongues N, de Sèze J, Cohen M, Lebrun-Frenay C, Hadhoum N, Zéphir H, Deschamps R, Carra-Dallière C, Labauge P, Kerschen P, Montcuquet A, Wiertlewski S, Laplaud D, Runavot G, Vukusic S, Papeix C, Marignier R; OFSEP, SFSEP, and NOMADMUS study groups.
Maillart E, et al.
J Neuroinflammation. 2020 Apr 23;17(1):128. doi: 10.1186/s12974-020-01773-w.
J Neuroinflammation. 2020.
PMID: 32326965
Free PMC article.